83 FR 55739 - Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium

DEPARTMENT OF JUSTICE
Antitrust Division

Federal Register Volume 83, Issue 216 (November 7, 2018)

[Federal Register Volume 83, Number 216 (Wednesday, November 7, 2018)]
[Notices]
[Page 55739]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-24335]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on October 16, 2018, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense 
Consortium (``MCDC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Allegheny-Singer Research Institute DBA AHN Institute, 
Pittsburgh, PA; Allotropic Tech, Halethorpe, MD; ASELL LLC, Owings 
Mills, MD; Clear Scientific LLC, Cambridge, MA; FLIR Detection, Inc., 
Stillwater, OK; FORGE Life Sciences, LLC, Doylestown, PA; IDBiologics, 
Inc., Nashville, TN; ImmPORT Therapeutics Inc. DBA Antigen Discovery 
Inc., Irvine, CA; Polo Custom Products, Topeka, KS; SIGA Technologies, 
Inc., New York, NY; The Albert Sabin Vaccine Institute, Inc. DBA Sabin 
Vaccine Institute, Washington, DC; VenatoRx Pharmaceuticals, Inc., 
Malvern, PA; and Windgap Medical, Inc., Watertown, MA, have been added 
as parties to this venture.
    Also, Artificial Cell Technologies, Inc., New Haven, CT; Celdara 
Medical, LLC, Lebanon, NH; HORIBA Instruments, Inc., Edison, NY; 
Macromoltek, Austin, TX; Philips Healthcare, Andover, MA; Phosphorex 
Inc., Hopkinton, MA; PPD Development LP, Wilmington, NC; Sequoia 
Consulting Group, LLC, Lake Forest, CA; and University of Tennessee, 
Knoxville, Knoxville, TN, have withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on August 3, 
2018. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on August 24, 2018 (83 FR 42940).

Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2018-24335 Filed 11-6-18; 8:45 am]
 BILLING CODE 4410-11-P